Semaglutide (Ozempic®) Use in Denmark 2018 Through 2023 ‒ User Trends and off-Label Prescribing for Weight Loss
Introduction Worldwide the prevalence of obesity and type 2 diabetes (T2D) is high and rapidly increasing.1 Substantial progress has been made over the past decade in the pharmacological management of T2D,2,3 and recently also obesity.4,5 In developed …